Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 70518-4198

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 70518-4198). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Metoprolol Succinate extended-release tablets, 25 mg strength, in a package containing 90 film-coated tablets. The label shows the NDC 70518-4198-00 and indicates repackaging by RemedyRepack Inc. The manufacturer listed is Ascend Labs, LLC, Montvale, NJ. Storage instructions are included along with a barcode and a QR code.*
FDA Label Image

Metoprolol-structure (Metoprolol Structure)

Metoprolol-structure (Metoprolol Structure)
Chemical structure of Metoprolol Succinate showing the molecular arrangement of atoms including hydroxyl, ether, amine, and carboxyl functional groups consistent with the extended-release succinate form.*
FDA Label Image

Metoprolol-table1a (Metoprolol Table1a)

Metoprolol-table1a (Metoprolol Table1a)
A forest plot chart showing results for subgroups in the MERIT-HF study. It compares relative risk and 95% confidence intervals for three outcomes: Total Mortality; Total Mortality or All-Cause Hospitalization; and Total Mortality or Hospitalization for Heart Failure. The subgroups include demographic and clinical categories such as geographic region, NYHA class, ejection fraction, ischemic etiology, sex, race, prior myocardial infarction, diabetes status, hypertension status, and heart rate. The chart contrasts Metoprolol Succinate Extended-Release Tablets versus placebo outcomes for each subgroup.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.